Skip to main content
EYEG logo

AB Corporate Bond ETF

EYEGNASDAQAB FundsFixed Income

$33.66Today:- (-)1Y −7.23%

As of Oct 16, 2026 close

Assets (AUM)
$26.64M
Expense ratio
0.30%
Dividend yield
5.08%
Holdings
302
52-week range
$33.24$36.63
Volume (live)
-
Avg. volume (3M)
456

EYEG ETF: AB Corporate Bond ETF - Price, Holdings & Analysis

AB Corporate Bond ETF Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Price & Trading Activity
Day's Range$33.66 - $33.69
52-Week High$36.63
52-Week Low$33.24
Open$33.69
Volume (last close)600
Average Volume (3M)456
Performance Metrics
1 Day Change+0.67%
1 Month Change−1.33%
6 Month Change−5.33%
YTD Change−5.54%
1 Year Change−7.23%
Dividend Information
Annual Dividend$1.71
Dividend Yield5.08%
Last Dividend Ex-DateOct 1, 2026
Dividend Growth YoY−17.36%
Fund Characteristics
Assets (AUM)$26.64M
Expense Ratio0.30%
Total Holdings302
Inception DateDec 12, 2023
Technical Indicators
50-Day MA$34.10
200-Day MA$35.07
RSI38.63
Stochastic %K61.63
Stochastic %D42.20

Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology

Compare EYEG with other ETFs

EYEG at a Glance

AB Corporate Bond ETF (EYEG) is a fixed income ETF from AB Funds, launched in December 2023. It manages $26.64M in assets and charges a 0.30% expense ratio, about $30 a year per $10,000 invested.

As of its Oct 4, 2026 holdings, it holds 302 positions. The largest are Humana Inc. 3.7% (HUM.3.7 03.23.29, 0.52%), Kimberly-Clark Corporation 3.2% (KMB.3.2 04.25.29, 0.52%) and Pfizer Investment Enterprises Pte Ltd. 4.45% (PFE.4.45 05.19.28, 0.52%). The top 10 holdings make up 5.2% of the fund.

It pays distributions yielding 5.08% at the Oct 16, 2026 close, $1.71 per share over the trailing 12 months. As of the Oct 16, 2026 close, the share price is down 7.2% over one year (price change, excluding distributions).

Frequently Asked Questions About AB Corporate Bond ETF

What is the current price of EYEG?

The latest EYEG price is $33.66 (Oct 16, 2026 close). The 52-week range is $33.24–$36.63. The share price is down 7.2% over the past year (price change, excluding distributions).

What is the expense ratio for EYEG?

EYEG's annual expense ratio is 0.30%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Fixed Income ETFs in the ETF Screener.

Does EYEG pay dividends?

Yes, EYEG pays a 5.08% dividend yield (trailing 12 months, at the Oct 16, 2026 close). The most recent ex-dividend date was October 1, 2026. View full dividend history in the Dividends section.

What are the top holdings of EYEG?

As of Oct 4, 2026, EYEG's largest holdings are Humana Inc. 3.7% (0.5%), Kimberly-Clark Corporation 3.2% (0.5%), Pfizer Investment Enterprises Pte Ltd. 4.45% (0.5%) (combined weight: 1.6%). The fund holds 302 total positions. View the complete portfolio breakdown in the Holdings section.

How does EYEG compare to similar ETFs?

Compare EYEG (0.30% expense ratio, $27M AUM) against similar Fixed Income ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.